Cigna Corp. diskutieren
Cigna Corp.
WKN: A2PA9L / Symbol: CI / Name: Cigna / Aktie / Anbieter & Dienstleistungen / Large Cap /
234,55 €
1,18 %
The Cigna Group (NYSE: CI) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $394.00 price target on the stock, up previously from $392.00.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Truist Financial Co. from $420.00 to $390.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Barclays PLC from $420.00 to $339.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Morgan Stanley from $403.00 to $379.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Cantor Fitzgerald from $400.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Stephens from $410.00 to $380.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $360.00 price target on the stock, down previously from $415.00.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $400.00 to $375.00. They now have an "outperform" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $348.00 price target on the stock, down previously from $394.00.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at UBS Group AG from $410.00 to $390.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Truist Financial Co. from $390.00 to $375.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Cantor Fitzgerald from $350.00 to $365.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Mizuho from $360.00 to $384.00. They now have an "outperform" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) is now covered by analysts at Guggenheim. They set a "buy" rating and a $384.00 price target on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Truist Financial Co. from $375.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target lowered by analysts at Robert W. Baird from $388.00 to $362.00. They now have an "outperform" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Barclays PLC from $339.00 to $382.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Morgan Stanley from $379.00 to $390.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for CI provided by MarketBeat
Neueste Beiträge
Wolfe_Research in Verisk Analytics A diskutieren